Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Viremia D014766 4 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Brain Hemorrhage, Traumatic D020201 1 associated lipids
Bronchiectasis D001987 7 associated lipids
Anthrax D000881 1 associated lipids
Heart Injuries D006335 6 associated lipids
Arenaviridae Infections D001117 1 associated lipids
Neurologic Manifestations D009461 1 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Servillo L et al. Lysophospholipid transacetylase in the regulation of PAF levels in human monocytes and macrophages. 2006 FASEB J. pmid:16571775
Lee CM et al. Prehispanolone, a novel platelet activating factor receptor antagonist from Leonurus heterophyllus. 1991 Br. J. Pharmacol. pmid:1657264
Corfield DR et al. Mechanisms of platelet activating factor-induced changes in sheep tracheal blood flow. 1991 Br. J. Pharmacol. pmid:1657266
Kudolo GB et al. Autoradiographic localization of platelet-activating factor (PAF) binding sites in the rabbit endometrium during the peri-implantation period. 1991 Cell Tissue Res. pmid:1657393
Nakamura M et al. Molecular cloning and expression of platelet-activating factor receptor from human leukocytes. 1991 J. Biol. Chem. pmid:1657923
Heller R et al. Stimulation of platelet-activating factor synthesis in human endothelial cells by activation of the de novo pathway. Phorbol 12-myristate 13-acetate activates 1-alkyl-2-lyso-sn-glycero-3-phosphate:acetyl-CoA acetyltransferase and dithiothreitol-insensitive 1-alkyl-2-acetyl-sn-glycerol:CDP-choline cholinephosphotransferase. 1991 J. Biol. Chem. pmid:1657961
Thaete LG and Neerhof MG Endothelin and platelet-activating factor: significance in the pathophysiology of ischemia/reperfusion-induced fetal growth restriction in the rat. 2006 Am. J. Obstet. Gynecol. pmid:16579936
Karantonis HC et al. In vivo antiatherogenic properties of olive oil and its constituent lipid classes in hyperlipidemic rabbits. 2006 Nutr Metab Cardiovasc Dis pmid:16580585
Balestrieri C et al. Relative effects of phenolic constituents from Yucca schidigera Roezl. bark on Kaposi's sarcoma cell proliferation, migration, and PAF synthesis. 2006 Biochem. Pharmacol. pmid:16580641
O'Flaherty JT et al. Tumor necrosis factor-alpha regulates expression of receptors for formyl-methionyl-leucyl-phenylalanine, leukotriene B4, and platelet-activating factor. Dissociation from priming in human polymorphonuclear neutrophils. 1991 J. Immunol. pmid:1658151
Walker BA et al. Absence of FMLP receptors on rat macrophages. 1991 J. Leukoc. Biol. pmid:1658174
Travers JB et al. Evidence for platelet-activating factor receptors in several B lymphoblastoid cell lines. 1991 Life Sci. pmid:1658521
Tomeo AC and Durán WN Resistance and exchange microvessels are modulated by different PAF receptors. 1991 Am. J. Physiol. pmid:1659229
Barnes PJ Platelet activating factor and asthma. 1991 Ann. N. Y. Acad. Sci. pmid:1659278
Hwang SB Function and regulation of extracellular and intracellular receptors of platelet activating factor. 1991 Ann. N. Y. Acad. Sci. pmid:1659279
O'Donnell M Effects of Ro 24-4736 in antagonizing the platelet and bronchoconstrictor responses to PAF. 1991 Ann. N. Y. Acad. Sci. pmid:1659287
Fernández B and Balsinde J Receptor-mediated activation of arachidonic acid release in mouse peritoneal macrophages is linked to extracellular calcium influx. 1991 Biochem. Biophys. Res. Commun. pmid:1659393
Kuruvilla A et al. High-level expression of functional platelet-activating factor receptors on a human B lymphoblastoid cell line. 1991 Biochem. Biophys. Res. Commun. pmid:1659411
Sánchez Crespo M and Fernández-Gallardo S Pharmacological modulation of PAF: a therapeutic approach to endotoxin shock. 1991 Sep-Oct J Lipid Mediat pmid:1659463
Zoratti EM et al. The effect of platelet-activating factor on the generation of superoxide anion in human eosinophils and neutrophils. 1991 J. Allergy Clin. Immunol. pmid:1659593
Coleus forskohlii. Monograph. 2006 Altern Med Rev pmid:16597194
Gay JC and Murray JJ Differential effects of propranolol on responses to receptor-dependent and receptor-independent stimuli in human neutrophils. 1991 Biochim. Biophys. Acta pmid:1659906
Ganong BR Roles of lipid turnover in transmembrane signal transduction. 1991 Am. J. Med. Sci. pmid:1661067
Murphy CT et al. Comparison of the role of protein kinase C in platelet functional responses induced by three different mechanisms, PAF, ionomycin and arachidonic acid. 1991 Biochim. Biophys. Acta pmid:1661165
Pitman JM et al. WEB2170, a specific platelet-activating factor antagonist, attenuates neutrophil priming by human serum after clinical burn injury: the 1991 Moyer Award. 1991 Sep-Oct J Burn Care Rehabil pmid:1661287
Massey CV et al. Molecular and cellular actions of platelet-activating factor in rat heart cells. 1991 J. Clin. Invest. pmid:1661298
Maliba R et al. Angiopoietins-1 and -2 are both capable of mediating endothelial PAF synthesis: intracellular signalling pathways. 2006 Cell. Signal. pmid:16617006
Taylor IK et al. Inhaled PAF stimulates leukotriene and thromboxane A2 production in humans. 1991 J. Appl. Physiol. pmid:1661723
Ueda N et al. Receptor-mediated increase in cytosolic calcium in LLC-PK1 cells by platelet activating factor and thromboxane A2. 1991 Kidney Int. pmid:1662319
Tou J et al. Accumulation of phosphatidic acid mass and increased de novo synthesis of glycerolipids in platelet-activating-factor-activated human neutrophils. 1991 Biochem. J. pmid:1662484
Ostermann G et al. Species-dependent differences of high affinity [3H]PAF-binding to platelets from humans and pigs and its inhibition by selected antagonists. 1991 J Lipid Mediat pmid:1662546
Stewart AG and Grigoriadis G Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages. 1991 J Lipid Mediat pmid:1662547
Haller H et al. Endothelin increases [Ca2+]i, protein phosphorylation, and O2-. production in human alveolar macrophages. 1991 Am. J. Physiol. pmid:1662920
Houlihan WJ et al. Synthesis and pharmacology of a novel class of long-lasting PAF receptor antagonists. 1991 Jan-Feb J Lipid Mediat pmid:1662991
Wu T et al. Platelet-activating factor stimulates eicosanoid production in cultured feline tracheal explants. 1991 Nov-Dec Exp. Lung Res. pmid:1663033
Nagaoka J et al. Inhibitory effects of the novel platelet activating factor receptor antagonist, 1-ethyl-2-[N-(2-methoxy)benzoyl-N-[(2R)-2-methoxy-3-(4- octadecylcarbamoyloxy) piperidinocarbonyloxypropyloxy]carbonyl] aminomethyl-pyridinium chloride, in several experimentally induced shock models. 1991 Arzneimittelforschung pmid:1663352
Olivier JL et al. Effects of platelet-activating factor (PAF), lyso-PAF and lysophosphatidylcholine on phosphatidylcholine bilayers, an ESR, 31P-NMR and X-ray diffraction study. 1991 May-Jun J Lipid Mediat pmid:1663404
Pugsley MK et al. Actions of platelet-activating factor on isolated rat hearts. 1991 Circ. Shock pmid:1663843
Vandongen R Platelet activating factor and the circulation. 1991 J. Hypertens. pmid:1663976
McMillan RM and Carter GW Design and development of drugs. 1991 Agents Actions Suppl. pmid:1664186
Pedersen KE et al. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin. 1991 Br. J. Pharmacol. pmid:1664758
Grigoriadis G and Stewart AG 1-O-hexadecyl-2-acetyl-sn-glycero-3-phospho (N,N,N trimethyl) hexanolamine: an analogue of platelet-activating factor with partial agonist activity. 1991 Br. J. Pharmacol. pmid:1664761
Heon Seo K et al. Platelet-activating factor induces up-regulation of antiapoptotic factors in a melanoma cell line through nuclear factor-kappaB activation. 2006 Cancer Res. pmid:16651419
Doi K et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. 2006 Am. J. Pathol. pmid:16651609
Desaulniers P et al. Characterization of an activation factor released from human neutrophils after stimulation by triclinic monosodium urate crystals. 2006 J. Rheumatol. pmid:16652423
Chan WP and Levy JV Effects of antiplatelet agents on platelet aggregation induced by platelet--activating factor (PAF) in human whole blood. 1991 Prostaglandins pmid:1665568
Stewart AG and Harris T Involvement of platelet-activating factor in endotoxin-induced priming of rabbit polymorphonuclear leukocytes. 1991 Mar-Apr J Lipid Mediat pmid:1665713
Salvidio G et al. Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis. 1991 Mar-Apr J Lipid Mediat pmid:1665716
Alving K et al. Effect of nedocromil sodium on allergen-, PAF-, histamine- and bradykinin-induced airways vasodilatation and pulmonary obstruction in the pig. 1991 Br. J. Pharmacol. pmid:1665736
Sagach VF and Zhukova AV [The effect of platelet-activating factor on cardio- and hemodynamics]. 1991 Fiziol Zh SSSR Im I M Sechenova pmid:1666599
Peng SY et al. Effect of ginkgolide B on the platelet-activating factor induced changes of chemotaxis and cytoskeleton of macrophages. 2006 Yao Xue Xue Bao pmid:16671547
Schauer U et al. Enhanced superoxide generation by eosinophils from asthmatic children. 1991 Int. Arch. Allergy Appl. Immunol. pmid:1667183
Hu WM and Man RY Differential actions of platelet-activating factor (PAF) receptor antagonists on the vasodilator and vasoconstrictor effects of PAF in the rat perfused heart. 1991 Br. J. Pharmacol. pmid:1667284
Filep JG et al. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor. 1991 Br. J. Pharmacol. pmid:1667286
Miller LG et al. Platelet activating factor antagonists interact with GABAA receptors. 1991 Res. Commun. Chem. Pathol. Pharmacol. pmid:1667341
Bate C et al. Platelet-activating factor antagonists protect amyloid-beta damaged neurons from microglia-mediated death. 2006 Neuropharmacology pmid:16678220
Sánchez FA et al. Functional significance of differential eNOS translocation. 2006 Am. J. Physiol. Heart Circ. Physiol. pmid:16679407
Yue TL et al. Platelet-activating factor (PAF)--a putative mediator in inflammatory tissue injury. 1991 Adv. Exp. Med. Biol. pmid:1667965
Chou CT et al. Neutrophil chemiluminescence and superoxide production in patients with rheumatoid arthritis: the effect of zymosan, phorbol myristate acetate and platelet-activating factor. 1991 Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi pmid:1667989
Shukla SD Inositol phospholipid turnover in PAF transmembrane signalling. 1991 Lipids pmid:1668102
Gandhi CR and Olson MS PAF effects on transmembrane signaling pathways in rat Kupffer cells. 1991 Lipids pmid:1668103
Stewart AG and Harris T Platelet-activating factor may participate in signal transduction processes in rabbit leukocytes. 1991 Lipids pmid:1668104
Ruis NM et al. Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor. 1991 Lipids pmid:1668105
Kudo I et al. Guinea pig bone marrow cells treated with platelet-activating factor generate factor(s) which affects their DNA synthesis and microbicidal activity. 1991 Lipids pmid:1668106
Braquet P et al. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins. 1991 Lipids pmid:1668107
Chau LY Protein kinase C is not involved in the desensitization of platelet activating factor receptor in rabbit platelets. 1991 Lipids pmid:1668108
Hwang SB and Lam MH L-659,989: a useful probe in the detection of multiple conformational states of PAF receptors. 1991 Lipids pmid:1668109
Shen TY Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists. 1991 Lipids pmid:1668110
Casals-Stenzel J Thieno-triazolo-1,4-diazepines as antagonists of platelet-activating factor: present status. 1991 Lipids pmid:1668111
Godfroid JJ et al. PAF receptor structure: a hypothesis. 1991 Lipids pmid:1668112
Lamotte-Brasseur J et al. PAF receptor and "Cache-oreilles" effect. Simple PAF antagonists. 1991 Lipids pmid:1668113
Yamada T et al. Pharmacological properties of YM461, a new orally active platelet-activating factor antagonist. 1991 Lipids pmid:1668114
Rossi AG and O'Flaherty JT Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor. 1991 Lipids pmid:1668115
Ammit AJ and O'Neill C Platelet-activating factor (PAF) receptor antagonists inhibit arachidonic acid induced platelet aggregation in rabbit whole blood. 1991 Lipids pmid:1668116
Hayashi H et al. Biological response of guinea pig peritoneal macrophages to platelet-activating factor. 1991 Lipids pmid:1668117
Pustynnikov MG et al. Platelet-activating factor stimulates receptor-mediated formation of reactive oxygen intermediates in human monocytes. 1991 Lipids pmid:1668118
Takahashi S et al. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes. 1991 Lipids pmid:1668119
Hernando P et al. IgA immune aggregates stimulate platelet-activating factor and superoxide anion production by human neutrophils. A comparison with IgG aggregates. 1991 Lipids pmid:1668120
Bazan NG et al. Platelet-activating factor and polyunsaturated fatty acids in cerebral ischemia or convulsions: intracellular PAF-binding sites and activation of a fos/jun/AP-1 transcriptional signaling system. 1991 Lipids pmid:1668121
Suematsu M and Tsuchiya M Platelet-activating factor and granulocyte-mediated oxidative stress. Strategy for in vivo oxyradical visualization. 1991 Lipids pmid:1668122
Amorim CZ et al. Effect of PAF-acether antagonists on active anaphylactic mouse paw edema. 1991 Lipids pmid:1668123
Mao YJ et al. [Effect of ginkgolide B on the function of rat aorta smooth cells and U937 cells stimulated by oxLDL]. 2006 Yao Xue Xue Bao pmid:16683525
Ko HM et al. Platelet-activating factor-induced NF-kappaB activation enhances VEGF expression through a decrease in p53 activity. 2006 FEBS Lett. pmid:16684540
Hruby ZW et al. Mechanisms of glomerular injury in experimental immune nephritis. II. Effect of a platelet activating factor receptor antagonist in an autologous nephritis model. 1991 Arch. Immunol. Ther. Exp. (Warsz.) pmid:1668710
Gottlieb OR The rational search for natural neolignans. 1991 Mem. Inst. Oswaldo Cruz pmid:1668770
Goldring WP and Pattenden G The phomactins. A novel group of terpenoid platelet activating factor antagonists related biogenetically to the taxanes. 2006 Acc. Chem. Res. pmid:16700534
McLaughlin NJ et al. Platelet-activating factor-induced clathrin-mediated endocytosis requires beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at the plasma membrane for actin bundle formation. 2006 J. Immunol. pmid:16709866
Givehchi A et al. Analysis of activity space by fragment fingerprints, 2D descriptors, and multitarget dependent transformation of 2D descriptors. 2006 May-Jun J Chem Inf Model pmid:16711727
Hsu HC et al. Alpha-bulnesene, a novel PAF receptor antagonist isolated from Pogostemon cablin. 2006 Biochem. Biophys. Res. Commun. pmid:16712790
Piwinski JJ et al. Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines. 1991 J. Med. Chem. pmid:1671420
Mathonnet M et al. Platelet-activating factor in cirrhotic liver and hepatocellular carcinoma. 2006 World J. Gastroenterol. pmid:16718768
Pons L et al. Role of free radicals and platelet-activating factor in the genesis of intestinal motor disturbances induced by Escherichia coli endotoxins in rats. 1991 Gastroenterology pmid:1672116
Cellai C et al. Growth inhibition and differentiation of human breast cancer cells by the PAFR antagonist WEB-2086. 2006 Br. J. Cancer pmid:16721373
Hermle T et al. Decreased cation channel activity and blunted channel-dependent eryptosis in neonatal erythrocytes. 2006 Am. J. Physiol., Cell Physiol. pmid:16723509
Fisher MA et al. Thrombin-mediated release of lipids from pulmonary artery endothelial cells promotes neutrophil adherence. 1991 Circ. Res. pmid:1672631
Verhoef G and Boogaerts M Treatment with granulocyte-macrophage colony stimulating factor and the adult respiratory distress syndrome. 1991 Am. J. Hematol. pmid:1672790
Fonseca FV et al. Characterization of a new platelet aggregating factor from crotoxin Crotalus durissus cascavella venom. 2006 Protein J. pmid:16729248
Symposium on The Clinical Importance of Leukotrienes and Platelet-activating Factor in Allergic Respiratory Diseases. November 14, 1990, San Francisco, California. 1991 Am. Rev. Respir. Dis. pmid:1673326
Kishino J et al. Synergistic effect of thromboxane A2 and N-formylmethionylleucylphenylalanine on platelet-activating factor synthesis in human polymorphonuclear neutrophils. 1991 Biochim. Biophys. Acta pmid:1673352
Lang F et al. Osmotic shock-induced suicidal death of erythrocytes. 2006 May-Jun Acta Physiol (Oxf) pmid:16734755